Back to Search
Start Over
Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells.
- Source :
-
Journal of dermatological science [J Dermatol Sci] 2024 Aug; Vol. 115 (2), pp. 54-63. Date of Electronic Publication: 2024 Jun 18. - Publication Year :
- 2024
-
Abstract
- Background: Psoriasis is an inflammatory skin disease with unclear pathogenesis and unmet therapeutic needs.<br />Objective: To investigate the role of senescent CD4 <superscript>+</superscript> T cells in psoriatic lesion formation and explore the application of senolytics in treating psoriasis.<br />Methods: We explored the expression levels of p16 <superscript>INK4a</superscript> and p21, classical markers of cellular senescence, in CD4 <superscript>+</superscript> T cells from human psoriatic lesions and imiquimod (IMQ)-induced psoriatic lesions. We prepared a senolytic gel using B-cell lymphoma 2 (BCL-2) inhibitor ABT-737 and evaluated its therapeutic efficacy in treating psoriasis.<br />Results: Using multispectrum immunohistochemistry (mIHC) staining, we detected increased expression levels of p16 <superscript>INK4a</superscript> and p21 in CD4 <superscript>+</superscript> T cells from psoriatic lesions. After topical application of ABT-737 gel, significant alleviation of IMQ-induced psoriatic lesions was observed, with milder pathological alterations. Mechanistically, ABT-737 gel significantly decreased the percentage of senescent cells, expression of T cell receptor (TCR) α and β chains, and expression of Tet methylcytosine dioxygenase 2 (Tet2) in IMQ-induced psoriatic lesions, as determined by mIHC, high-throughput sequencing of the TCR repertoire, and RT-qPCR, respectively. Furthermore, the severity of psoriatic lesions in CD4 <superscript>cre</superscript> Tet2 <superscript>f/f</superscript> mice was milder than that in Tet2 <superscript>f/f</superscript> mice in the IMQ-induced psoriasis model.<br />Conclusion: We revealed the roles of senescent CD4 <superscript>+</superscript> T cells in developing psoriasis and highlighted the therapeutic potential of topical ABT-737 gel in treating psoriasis through the elimination of senescent cells, modulation of the TCR αβ repertoire, and regulation of the TET2-Th17 cell pathway.<br />Competing Interests: Declaration of Competing Interest The authors have no relevant financial or non-financial interests to disclose.<br /> (Copyright © 2024 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Mice
Humans
DNA-Binding Proteins metabolism
DNA-Binding Proteins genetics
Proto-Oncogene Proteins metabolism
Proto-Oncogene Proteins antagonists & inhibitors
Administration, Cutaneous
Senotherapeutics pharmacology
Senotherapeutics administration & dosage
Senotherapeutics therapeutic use
Skin pathology
Skin drug effects
Skin immunology
Male
Gels
Female
Cyclin-Dependent Kinase Inhibitor p16 metabolism
Cyclin-Dependent Kinase Inhibitor p16 genetics
Mice, Inbred C57BL
Imiquimod administration & dosage
Psoriasis drug therapy
Psoriasis chemically induced
Psoriasis pathology
Psoriasis immunology
Cellular Senescence drug effects
Nitrophenols pharmacology
Nitrophenols administration & dosage
Sulfonamides pharmacology
Sulfonamides administration & dosage
Dioxygenases
Disease Models, Animal
Proto-Oncogene Proteins c-bcl-2 metabolism
Proto-Oncogene Proteins c-bcl-2 genetics
Piperazines pharmacology
Piperazines administration & dosage
Biphenyl Compounds pharmacology
Biphenyl Compounds therapeutic use
Biphenyl Compounds administration & dosage
CD4-Positive T-Lymphocytes drug effects
CD4-Positive T-Lymphocytes immunology
CD4-Positive T-Lymphocytes metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-569X
- Volume :
- 115
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of dermatological science
- Publication Type :
- Academic Journal
- Accession number :
- 38960840
- Full Text :
- https://doi.org/10.1016/j.jdermsci.2024.06.002